These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16019105)

  • 1. GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection.
    Sarrazin C; Berg T; Weich V; Mueller T; Frey UH; Zeuzem S; Gerken G; Roggendorf M; Siffert W
    J Hepatol; 2005 Sep; 43(3):388-93. PubMed ID: 16019105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
    Ahlenstiel G; Nischalke HD; Bueren K; Berg T; Vogel M; Biermer M; Grünhage F; Sauerbruch T; Rockstroh J; Spengler U; Nattermann J
    J Hepatol; 2007 Sep; 47(3):348-55. PubMed ID: 17559964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
    Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients.
    Al-Traif I; Handoo FA; Al-Jumah A; Al-Nasser M
    Saudi Med J; 2004 Dec; 25(12):1935-8. PubMed ID: 15711670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
    Nattermann J; Vogel M; Berg T; Danta M; Axel B; Mayr C; Bruno R; Tural C; Klausen G; Clotet B; Lutz T; Grünhage F; Rausch M; Nischalke HD; Schewe K; Bienek B; Haerter G; Sauerbruch T; Rockstroh JK; Spengler U;
    Hepatology; 2007 Oct; 46(4):1016-25. PubMed ID: 17668881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.
    Zeuzem S; Buti M; Ferenci P; Sperl J; Horsmans Y; Cianciara J; Ibranyi E; Weiland O; Noviello S; Brass C; Albrecht J
    J Hepatol; 2006 Jan; 44(1):97-103. PubMed ID: 16290907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
    Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel SNPs in the promoter region of PKR gene in hepatitis C patients and their impact on disease outcome and response to treatment.
    El-Dahshan D; Bahy D; Wahid A; Ahmed AE; Hanora A
    Arab J Gastroenterol; 2018 Sep; 19(3):106-115. PubMed ID: 30245117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia.
    Nückel H; Frey U; Aralh N; Dürig J; Dührsen U; Siffert W
    Leuk Lymphoma; 2003 Oct; 44(10):1739-43. PubMed ID: 14692527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G Protein β3 subunit gene C825T polymorphism and its association with the presence and clinicopathological characteristics of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    J Urol; 2012 Jul; 188(1):287-93. PubMed ID: 22608746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia.
    Oshima T; Nakajima S; Yokoyama T; Toyoshima F; Sakurai J; Tanaka J; Tomita T; Kim Y; Hori K; Matsumoto T; Miwa H
    BMC Med Genet; 2010 Jan; 11():13. PubMed ID: 20102604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.
    Eisenhardt A; Siffert W; Rosskopf D; Musch M; Mosters M; Roggenbuck U; Jöckel KH; Rübben H; Lümmen G
    World J Urol; 2005 Sep; 23(4):279-86. PubMed ID: 16133558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study.
    Sheppard R; Hsich E; Damp J; Elkayam U; Kealey A; Ramani G; Zucker M; Alexis JD; Horne BD; Hanley-Yanez K; Pisarcik J; Halder I; Fett JD; McNamara DM;
    Circ Heart Fail; 2016 Mar; 9(3):e002683. PubMed ID: 26915373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.